glp-1 agonists and inflammation Anti-inflammatory properties of receptor other ancillary benefits from a pharmacological perspective GLP-1 drugs calm inflammation beyond
Description
Renal Na(+)-glucose cotransporters
Lancet 392 , 21802193 (2018) D
Aoun L, Almardini S, Saliba F, Haddadin F, Mourad O, Jdaidani J, et al
At the 2mg dose, some patients see reductions approaching 2%
GLP-1 drugs slow digestion and suppress appetite, which can cause low energy from reduced nutrient intake or blood sugar fluctuations
[DOI] [PMC free article] [PubMed] [Google Scholar] 115.Natale P., Green S.C., Tunnicliffe D.J., Pellegrino G., Toyama T., Strippoli G.F
